ESOC 2020: Abstracts on NeuroAiD
In November 2020, ESO-WSO provided scientific updates to Health Care Practitioners. During this...
Embracing World Stroke Day 2020
World Stroke Day 2020 Stroke remains one of the main cause for disability worldwide. Moleac...
Highlights from Asia Pacific Stroke Organization (APSC) and World Congress of Neurology (WCN) Scientific Symposia
Two scientific symposia were conducted on the 2nd October 2019 and 29th October 2019. Multiple...
Highlights from European Stroke Organisation Conference (ESOC) Scientific Symposium
June 2019 A scientific symposium was held on the 24th May 2019, which aimed to share the advance...
Moleac holds two educational symposia on the management of Traumatic Brain Injury
March 2019 Moleac organized two symposia in Dubai and Bangkok on new approaches for Traumatic...
NeuroAiD combined with rehabilitation has shown additive and sustained benefits on post-stroke recovery over 2 years after an initial 3-month treatment following stroke onset
More subjects on NeuroAiD™ improved to functional independence compared to placebo among subjects...
Moleac Announces US FDA Approval of IND Application for Phase 1 Study of MLC1501 Programme in Post-Stroke Recovery
SINGAPORE, March 5, 2018 /PRNewswire/ — Moleac, a biopharmaceutical company focused on research...
NeuroAiD at ASEAN Neurological Association
Moleac will attend the 12th Biennial Convention of ASEAN Neurological Association (ASNA) &...
NeuroAiD at Asia Pacific Stroke Conference
Renowned clinicians and researchers will present abstracts from the latest studies conducted on...
